• Sirona Biochem Receives $500,000 Milestone from Wanbang contractpharma
    August 30, 2018
    Sirona Biochem has received a $500,000 milestone payment from partner Wanbang Biopharmaceuticals for approval by the China Food and Drug Administration (CFDA) of the Phase I clinical trial for Sirona's SGLT-2 inhibitor.......
PharmaSources Customer Service